![]() |
市场调查报告书
商品编码
1904617
精准发酵和细胞培养食品市场预测至2032年:按产品类型、形态、生产方法、技术、应用、最终用户和地区分類的全球分析Precision Fermentation & Cell-Cultured Food Market Forecasts to 2032 - Global Analysis By Product Type, Form, Production, Technology, Application, End User and By Geography |
||||||
根据 Stratistics MRC 的一项研究,全球精准发酵和细胞培养食品市场预计到 2025 年将价值 49 亿美元,到 2032 年达到 516.5 亿美元,在预测期内复合年增长率为 40.0%。
精准发酵和细胞培养食品是利用可控生物製程生产食品配料和产品的创新生物技术方法。精准发酵透过操控微生物来生产特定的化合物,例如蛋白质和脂肪;而细胞培养食品则透过培养动物细胞来生产肉类和乳製品,无需饲养牲畜。这些技术永续、资源更有效率的食品生产,减少对传统农业的依赖,并确保产品品质稳定,因此是满足未来世界蛋白质和营养需求的关键解决方案。
对替代蛋白质的需求日益增长
人们对环境永续性、动物福利和食品安全的日益关注,正加速推动对非传统蛋白质来源的兴趣。传统畜牧业因其温室气体排放量高、资源消耗大而备受批评,促使人们采用新型蛋白质技术。精准发酵技术能够生产出品质稳定、环境影响小的功能性蛋白质。同时,细胞培养食品在满足日益增长的蛋白质需求的同时,也解决了与动物屠宰相关的伦理问题。食品生物技术的进步提高了产品的可扩展性和安全性,增强了消费者的信任。随着弹性素食和气候友善饮食的日益普及,全球对新一代蛋白质解决方案的需求持续增长。
高昂的生产成本
此製程需要昂贵的反应器、培养基和严格的品管系统,增加了资本支出。将实验室製程放大到商业化生产规模面临巨大的技术和资金挑战。能源消耗和设施维护进一步增加了营运成本,限制了其与传统食品的价格竞争。监管合规和食品安全检验也增加了总支出。小规模公司往往难以获得资金筹措来支持漫长的研发週期。在成本效益提高之前,高昂的价格可能会阻碍其被大众市场接受。
杂交食品的兴起
混合食品将精准发酵或细胞培养的成分与植物来源成分结合,以改善口感、质地和营养价值。这种方法减少了对昂贵培养成分的依赖,同时提高了消费者的接受度。食品製造商正在利用混合配方加快产品上市速度并控制生产成本。成分配方的创新也使得产品能够根据特定的膳食需求和烹饪用途进行客製化。混合产品的监管流程通常比完全培养食品更简单,从而加快了上市速度。随着对价格合理且可持续的蛋白质替代品的需求不断增长,混合解决方案正吸引业界的广泛关注。
供应链脆弱性
此领域高度依赖培养基、微生物菌株和生物加工设备等专用投入品。原材料供应中断会导致生产延误和成本增加。由于全球生物技术组件来源有限,依赖性风险加剧。运输瓶颈和地缘政治不确定性也对物流网络带来额外压力。各公司正积极探索在地化生产和垂直整合以应对这些挑战。如果没有稳健的供应链策略,营运规模化和及时商业化可能会受到限制。
新冠疫情对精准发酵和细胞培养食品产业产生了重大影响。封锁和贸易限制扰乱了研究活动、中试生产和全球供应链。不确定性影响了资金筹措优先事项,导致投资流动暂时放缓。然而,疫情凸显了传统肉类供应链的脆弱性,并提高了人们对具有韧性的食品体系的关注。消费者对食品安全、可追溯性和永续性的关注增强了对替代蛋白的支持。疫情过后,各国政府和私人投资者恢復了对食品创新和生物技术的支持。因此,儘管短期内业务受到干扰,但长期市场前景有所改善。
预计在预测期内,培养肉细分市场将占据最大的市场份额。
由于与传统动物蛋白质高度相似,预计在预测期内,培养肉将占据最大的市场份额。培养肉不仅口感、质地和营养成分与传统动物肉相似,也避免了畜牧业带来的环境负担。大型食品公司和创业投资不断增加的投资正在加速产品研发。部分地区的监管核准正在提升市场信誉度和商业化前景。细胞株开发和反应器效率的提升提高了生产的可行性。随着透明度和消费者认知度的提高,人造肉的接受度也逐渐提高。
预计在预测期内,替代蛋白品牌细分市场将呈现最高的复合年增长率。
预计在预测期内,替代蛋白品牌细分市场将实现最高成长率。各品牌正大力投资行销、产品创新和消费者互动。强大的品牌影响力有助于建立消费者对精准发酵和发酵食品等新技术的信任。与直销 (D2C) 和餐饮服务业的合作正在扩大品牌知名度。产品快速多元化,包括零食、乳製品替代品和机能性食品,正在推动销售成长。此外,各品牌也透过强调永续性来吸引年轻消费族群。
由于北美地区拥有强大的创新生态系统,预计该地区将在预测期内占据最大的市场份额。该地区受惠于先进的生物技术基础和雄厚的研发投入。众多领先的Start-Ups、研究机构和成熟的食品公司为快速商业化提供了支持。良好的资金筹措环境和创业投资活动正在加速技术突破。监管机构正逐步完善新型食品核准框架。消费者对替代蛋白的高度认知和接受意愿进一步巩固了其市场领导地位。
由于人口增长和蛋白质需求上升,预计亚太地区在预测期内将实现最高的复合年增长率。快速的都市化和收入成长正在改变全部区域的饮食习惯。各国政府正加强对粮食安全和永续蛋白质倡议的支持。中国、新加坡和日本等国正在投资细胞农业和发酵技术。某些市场的监管发展正在推动试点项目和商业化。本地製造商正与全球创新者合作,以加速技术的应用。
According to Stratistics MRC, the Global Precision Fermentation & Cell-Cultured Food Market is accounted for $4.90 billion in 2025 and is expected to reach $51.65 billion by 2032 growing at a CAGR of 40.0% during the forecast period. Precision Fermentation & Cell-Cultured Food encompasses innovative methods that leverage biotechnology to produce food ingredients and products through controlled biological processes. Precision fermentation engineers microbes to generate targeted compounds such as proteins or fats, whereas cell-cultured food involves cultivating animal cells to create meat or dairy without raising livestock. These technologies support more sustainable, resource-efficient food production, lower dependence on traditional agriculture, and enable consistent quality, making them key solutions for future global protein and nutrition demands.
Rising demand for alternative proteins
Increasing awareness of environmental sustainability, animal welfare, and food security is accelerating interest in non-traditional protein sources. Conventional livestock farming faces criticism due to high greenhouse gas emissions and resource intensity, encouraging adoption of novel protein technologies. Precision fermentation enables the production of functional proteins with consistent quality and reduced environmental impact. Meanwhile, cell-cultured foods address ethical concerns associated with animal slaughter while meeting rising protein needs. Advancements in food biotechnology are improving scalability and product safety, strengthening consumer trust. As flexitarian and climate-conscious diets gain popularity, demand for next-generation protein solutions continues to expand globally.
High production costs
The process requires expensive bioreactors, growth media, and stringent quality control systems, increasing capital expenditure. Scaling laboratory processes to commercial production presents significant technical and financial challenges. Energy consumption and facility maintenance further elevate operating costs, limiting price competitiveness with conventional foods. Regulatory compliance and food safety validation also add to overall expenditure. Smaller companies often struggle to secure sufficient funding to support long development cycles. Until cost efficiencies improve, high prices may restrict mass-market adoption.
Advancements in hybrid food products
Hybrid foods combine precision-fermented or cell-cultured ingredients with plant-based components to enhance taste, texture, and nutritional value. This approach reduces reliance on costly cultured inputs while improving consumer acceptance. Food manufacturers are leveraging hybrid formulations to accelerate commercialization and manage production expenses. Innovation in ingredient blending is also enabling customization for specific dietary needs and culinary applications. Regulatory pathways for hybrid products are often simpler than for fully cultured foods, supporting faster market entry. As demand for affordable and sustainable protein alternatives rises, hybrid solutions are gaining strong industry interest.
Supply chain vulnerabilities
The sector relies heavily on specialized inputs such as growth media, microbial strains, and bioprocessing equipment. Disruptions in raw material availability can delay production and increase costs. Limited global suppliers for biotechnological components heighten dependency risks. Transportation bottlenecks and geopolitical uncertainties further strain logistics networks. Companies are increasingly exploring localized production and vertical integration to mitigate these challenges. Without resilient supply chain strategies, scalability and timely commercialization may be constrained.
The COVID-19 pandemic significantly influenced the precision fermentation and cell-cultured food industry. Lockdowns and trade restrictions disrupted research activities, pilot production, and global supply chains. Investment flows slowed temporarily as uncertainty affected funding priorities. However, the pandemic highlighted vulnerabilities in traditional meat supply chains, increasing interest in resilient food systems. Consumer focus on food safety, traceability, and sustainability strengthened the case for alternative proteins. Governments and private investors renewed support for food innovation and biotechnology post-pandemic. As a result, long-term market prospects improved despite short-term operational disruptions.
The cultured meat segment is expected to be the largest during the forecast period
The cultured meat segment is expected to account for the largest market share during the forecast period, due to its close resemblance to conventional animal protein. Cultured meat offers authentic taste, texture, and nutritional profiles without the environmental burden of livestock farming. Increasing investments from food giants and venture capital firms are accelerating product development. Regulatory approvals in select regions are improving market confidence and commercialization prospects. Advances in cell-line development and bioreactor efficiency are enhancing production feasibility. Consumer acceptance is gradually improving as transparency and education increase.
The alternative protein brands segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the alternative protein brands segment is predicted to witness the highest growth rate. Branded companies are actively investing in marketing, product innovation, and consumer engagement. Strong branding helps build trust around novel technologies such as precision fermentation and cultured foods. Direct-to-consumer and foodservice partnerships are expanding brand visibility. Rapid product diversification, including snacks, dairy alternatives, and functional foods, is driving sales growth. Brands are also leveraging sustainability messaging to appeal to younger demographics.
During the forecast period, the North America region is expected to hold the largest market share, due to its strong innovation ecosystem. The region benefits from advanced biotechnology infrastructure and robust R&D investment. The presence of leading startups, research institutions, and established food companies supports rapid commercialization. Favorable funding environments and venture capital activity are accelerating technological breakthroughs. Regulatory agencies are gradually developing frameworks for novel food approvals. High consumer awareness and willingness to adopt alternative proteins further support market leadership.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rising population and protein demand. Rapid urbanization and income growth are reshaping dietary preferences across the region. Governments are increasingly supporting food security and sustainable protein initiatives. Countries such as China, Singapore, and Japan are investing in cellular agriculture and fermentation technologies. Regulatory progress in select markets is enabling pilot launches and commercialization. Local manufacturers are collaborating with global innovators to accelerate adoption.
Key players in the market
Some of the key players in Precision Fermentation & Cell-Cultured Food Market include Impossible, Perfect Day, Geltor, The EVERY Co, Motif FoodWorks, Imagindairy, Change Foods, New Culture, Eden Brew, Triton Algae Innovations, Remilk, Nature's Fynd, Aleph Farms, SuperMeat, and Vow.
In March 2025, Earthbar in partnership with The EVERY Company, Earthbar is rolling out two Limited Time Offering ("LTO") drinks: the Protein Mocha Latte and Protein Matcha Latte. Each latte packs an impressive 12 to 13 grams of protein per serving without any compromise on taste or texture. The secret ingredient is EVERY's game-changing protein-boosted beverage syrup, featuring EVERY OvoBoost(TM), a highly soluble, highly digestible egg white protein.
In February 2024, Perfect Day has partnered with Unilever's Breyers, a family favorite since 1866, to launch Breyers Lactose-Free Chocolate made with Perfect Day's dairy protein from fermentation. Perfect Day uses a decades-old process of precision fermentation to create its highly functional whey protein that offers the same indulgent experience consumers have loved for decades without any lactose and with a reduced environmental footprint.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.